Abstract
The objective of this study was to investigate the role of induced cytokines, tumor infiltrating cells and nitric oxide (NO) in anti-tumor activity upon intratumoral injection of free and condensed plasmid DNA encoding murine interleukin-12 (pmIL-12) into BALB/c mice bearing subcutaneous tumors. Poly[α-(4-aminobutyl)-L-glycolic acid] (PAGA) was used for complex formation with pmIL-12 in presence of 5% (w/v) glucose. Upon characterization, PAGA/pmIL-12 (3/1, ±) complexes were found to be most effective in gene transfer and were used consistently throughout this study. The levels of mIL-12 p70 and induced cytokines were determined by ELISA in the supernatant of the cultured tumors of the CT-26 subcutaneous tumor bearing BALB/c female mice 48 h after intratumoral injection of PAGA/pmIL-12 complexes and naked pmIL-12. The levels of IL-12, IFN-γ, TNF-α and NO were higher for the PAGA/pmIL-12 complexes than those for the naked pmIL-12, PAGA alone and 5% glucose injected groups. The relative presence of natural killer (NK) cells, CD4+ T cells, and antigen presenting cells, such as macrophages and dendritic cells determined using immunohistochemistry was higher for PAGA/pmIL-12 complexes compared with naked pmIL-12. The presence of CMV promoter in plasmid encoding IL-12 cDNAs did not induce any type I interferon response. There was a significant improvement in the survival rate and the inhibition of tumor growth after repeated injections of PAGA/pmIL-12 complexes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Brunda MJ et al. Antitumor and antimetastatic activity of interleukin-12 against murine tumors J Exp Med 1993 178: 1223–1230
Rakhmilevich AL et al. Cytokine gene therapy of cancer using gene gun technology: superior antitumor activity of interleukin-12 Hum Gene Ther 1997 8: 1303–1311
Tahara H et al. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector J Immunol 1995 154: 6466–6474
Smyth MJ, Taniguchi M, Street SEA . The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent J Immunol 2000 165: 2665–2670
Fernandez NC et al. High frequency of specific CD8+ T cells in the tumor and blood is associated with efficient local IL-12 gene therapy of cancer J Immunol 1999 162: 609–617
Martinotti A et al. CD4 T cells inhibits in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes Eur J Immunol 1995 25: 137–146
Mendiratta SK et al. Intratumoral delivery of IL-12 gene by polyvinyl polymeric vector system to murine renal and colon carcinoma results in potent antitumor immunity Gene Therapy 1999 6: 833–839
Mendiratta SK et al. Combination of interleukin-12 and interferon-α gene therapy induces a synergistic anti-tumor response against colon and renal carcinoma Hum Gene Ther 2000 11: 1851–1862
Han SO, Mahato RI, Sung YK, Kim SW . Development of biomaterials for gene therapy Mol Ther 2000 2: 302–317
Maheshwari A et al. Soluble biodegradable polymer-based cytokine gene delivery for cancer treatment Mol Ther 2000 2: 121–130
Haicheur N et al. Cytokine and soluble cytokine receptor induction after IL-12 administration in cancer patients Clin Exp Immunol 2000 119: 28–37
Coleman M et al. Nonviral interferon-α gene therapy inhibits growth of established tumors by eliciting a systemic immune response Hum Gene Ther 1998 9: 2223–2230
Dong Z et al. Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-β Cancer Res 1999 59: 872–879
Bogdan C, Rollinghoff M, Diefenbach A . The role of nitric oxide in innate immunity Immunol Rev 2000 173: 17–26
Nishioka Y et al. Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin-12 Cancer Res 1999 59: 4035–4041
Rakhmilevich AL et al. Gene gun-mediated IL-12 gene therapy induces antitumor effects in the absence of toxicity: a direct comparison with systemic IL-12 protein therapy J Immunother 1999 22: 135–144
Trinchieri G . Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridges innate resistance and antigen-specific adaptive immunity Annu Rev Immunol 1995 13: 251–276
Lim YB et al. Development of a safe gene delivery system using biodegradable polymer, poly[α- (4-aminobutyl)-L-glycolic acid] J Am Chem Soc 2000 122: 6524–6525
Diefenbach A et al. Requirement for type 2 NO-synthase for IL-12 responsiveness in innate immunity Science 1999 284: 951–955
Nastala CL et al. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production J Immunol 1994 153: 1697–1706
Nagayama H et al. IL-12 responsiveness and expression of IL-12 receptor in human peripheral blood monocyte-derived dendritic cells J Immunol 2000 165: 59–66
Duda DG et al. Direct in vitro evidence and in vivo analysis of the angiogenesis effects of interleukin-12 Cancer Res 2000 60: 1111–1116
Lanuti M et al. Cationic lipid: bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor models Cancer Res 2000 60: 2955–2963
Li D et al. Combination surgery and non-viral interleukin-2 gene therapy for head and neck cancer Clin Cancer Res 1999 5: 1551–1556
Schultz J et al. Long lasting anti-metastatic efficiency of interleukin-12 encoding plasmid DNA Hum Gene Ther 1999 10: 407–417
Freimark BD et al. Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: cationic lipid complexes J Immunol 1998 160: 4580–4586
Zhou A et al. Exogenous interferon-γ induces endogenous synthesis of interferon-α and -β by murine macrophages for induction of nitric oxide synthase J Interfer Cytokine Res 1995 15: 897–904
Brunda MJ et al. Role of interferon-γ in mediating the anti-tumor efficacy of interleukin-12 J Immunother 1995 17: 71–77
Mahato RI . Polymeric gene delivery for cancer treatment Park KD (eds); Biomaterials and Drug Delivery towards New Millennium Han Rim Won Publishing 2000 pp 249–280
Ghazizadeh S, Carroll JM, Taichman LB . Repression of retrovirus-mediated transgene expression by interferons: implications for gene therapy J Virol 1997 71: 9163–9169
Sareneva T, Julkunen I, Matikainen S . IFN-α and IL-12 induces IL-18 receptor gene expression in human NK and T cells J Immunol 2000 165: 1933–1938
Pham-Nguyen KB et al. Role of NK and T cells in IL-12-induced anti-tumor response against hepatic colon carcinoma Int J Cancer 1999 81: 813–819
Ha SJ et al. Rapid recruitment of macrophages in interleukin-12 mediated tumor regression Immunology 1998 95: 156–163
Koch F et al. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10 J Exp Med 1996 184: 741–746
Caruso M et al. Adenovirus mediated interleukin-12 gene therapy for metastatic colon carcinoma Proc Natl Acad Sci USA 1996 93: 1302–1306
Mizuguchi H et al. Tumor necrosis factor α-mediated tumor regression by the in vivo transfer of genes into the artery that leads to tumor Cancer Res 1998 58: 5725–5730
Gately MK et al. The interleukin-12/interleukin-12 receptor system: role in normal and pathogenic immune responses Annu Rev Immunol 1998 16: 495–521
Gately MK et al. The interleukin-12/interleukin-12 receptor system: role in normal and pathogenic immune responses Rakhmilevich AI, Yang NS. IL-12 gene therapy of tumors. US Patent 1999; 5: 922, 685.
Okada E et al. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens J Immunol 1997 159: 3638–3647
Dow SW et al. Intravenous cytokine gene delivery by lipid-DNA complexes controls the growth of established lung metastases Hum Gene Ther 1999 10: 2961–2972
Lim YB et al. Biodegradable polyester, poly[(-(4-aminobutyl)-L-glycolic acid], as a non-toxic gene carrier Pharm Res 2000 17: 811–816
Tannenbaum CS et al. Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12 J Immunol 1996 156: 693–699
Acknowledgements
Our special thanks to Kelley Murphy of Huntsman Cancer Institute, University of Utah for immunohistochemistry related experiments. We also thank Alex Zlotnikov for technical assistance and Expression Genetics, for financial support.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maheshwari, A., Han, S., Mahato, R. et al. Biodegradable polymer-based interleukin-12 gene delivery: role of induced cytokines, tumor infiltrating cells and nitric oxide in anti-tumor activity. Gene Ther 9, 1075–1084 (2002). https://doi.org/10.1038/sj.gt.3301766
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301766
Keywords
This article is cited by
-
Double domain polyethylenimine-based nanoparticles for integrin receptor mediated delivery of plasmid DNA
Scientific Reports (2018)
-
Comparison of the effectiveness of polyethylenimine, polyamidoamine and chitosan in transferring plasmid encoding interleukin-12 gene into hepatocytes
Macromolecular Research (2013)
-
Drug Delivery Using Nanocarriers: Indian Perspective
Proceedings of the National Academy of Sciences, India Section B: Biological Sciences (2012)
-
Effective transfer of interleukin-12 gene to solid tumors using a novel gene delivery system, poly [D,L-2,4-diaminobutyric acid]
Cancer Gene Therapy (2004)
-
Adenovirus-based vascular endothelial growth factor gene delivery to human pancreatic islets
Gene Therapy (2004)